Keep an eye on the top gainers and losers in Thursday's session. Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Korro Bio Early Trial Results Fall Short; Stock Hits New Low Korro Bio shares drop after KRRO-110 trial in AATD misses protein goals; company cuts 34% of staff and shifts focus to liver-targeted programs.
Which stocks are gapping on Thursday? The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.
Korro Bio Plummets To A Record Low On A Big Setback In RNA-Editing Korro Bio stock plummeted Thursday after its RNA-editing drug failed in patients with a rare lung and liver disease.
Stay updated with the stocks that are on the move in today's pre-market session. The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.
Novo Nordisk Inks $600M Genetic Medicines Pact With Canadian Firm To Target Cardiometabolic Indications Wednesday, Canada-based NanoVation Therapeutics announced a multi-year partnership with Novo Nordisk A/S (
NYSE:NVO ) to advance the ...
